TY - JOUR
T1 - Prediction of residues involved in inhibitor specificity in the dihydrofolate reductase family
AU - Goodey, N. M.
AU - Herbert, K. G.
AU - Hall, S. M.
AU - Bagley, K. C.
PY - 2011/12
Y1 - 2011/12
N2 - Dihydrofolate reductase (DHFR) is of significant recent interest as a target for drugs against parasitic and opportunistic infections. Understanding factors which influence DHFR homolog inhibitor specificity is critical for the design of compounds that selectively target DHFRs from pathogenic organisms over the human homolog. This paper presents a novel approach for predicting residues involved in ligand discrimination in a protein family using DHFR as a model system. In this approach, the relationship between inhibitor specificity and amino acid composition for sets of protein homolog pairs is examined. Similar inhibitor specificity profiles correlate with increased sequence homology at specific alignment positions. Residue positions that exhibit the strongest correlations are predicted as specificity determinants. Correlation analysis requires a quantitative measure of similarity in inhibitor specificity (S lig) for a pair of homologs. To this end, a method of calculating Slig values using KI values for the two homologs against a set of inhibitors as input was developed. Correlation analysis of S lig values to amino acid sequence similarity scores - obtained via multiple sequence alignments - was performed for individual residue alignment positions and sets of residues on 13 DHFRs. Eighteen alignment positions were identified with a strong correlation of Slig to sequence similarity. Of these, three lie in the active site; four are located proximal to the active site, four are clustered together in the adenosine binding domain and five on the βFβG loop. The validity of the method is supported by agreement between experimental findings and current predictions involving active site residues.
AB - Dihydrofolate reductase (DHFR) is of significant recent interest as a target for drugs against parasitic and opportunistic infections. Understanding factors which influence DHFR homolog inhibitor specificity is critical for the design of compounds that selectively target DHFRs from pathogenic organisms over the human homolog. This paper presents a novel approach for predicting residues involved in ligand discrimination in a protein family using DHFR as a model system. In this approach, the relationship between inhibitor specificity and amino acid composition for sets of protein homolog pairs is examined. Similar inhibitor specificity profiles correlate with increased sequence homology at specific alignment positions. Residue positions that exhibit the strongest correlations are predicted as specificity determinants. Correlation analysis requires a quantitative measure of similarity in inhibitor specificity (S lig) for a pair of homologs. To this end, a method of calculating Slig values using KI values for the two homologs against a set of inhibitors as input was developed. Correlation analysis of S lig values to amino acid sequence similarity scores - obtained via multiple sequence alignments - was performed for individual residue alignment positions and sets of residues on 13 DHFRs. Eighteen alignment positions were identified with a strong correlation of Slig to sequence similarity. Of these, three lie in the active site; four are located proximal to the active site, four are clustered together in the adenosine binding domain and five on the βFβG loop. The validity of the method is supported by agreement between experimental findings and current predictions involving active site residues.
KW - Allosteric interaction
KW - Dihydrofolate reductase
KW - Drug-target interaction
KW - Inhibitor specificity
KW - Specificity determinant
KW - Target prediction
UR - http://www.scopus.com/inward/record.url?scp=81755179386&partnerID=8YFLogxK
U2 - 10.1016/j.bbapap.2011.08.001
DO - 10.1016/j.bbapap.2011.08.001
M3 - Article
C2 - 21840427
AN - SCOPUS:81755179386
SN - 1570-9639
VL - 1814
SP - 1870
EP - 1879
JO - Biochimica et Biophysica Acta - Proteins and Proteomics
JF - Biochimica et Biophysica Acta - Proteins and Proteomics
IS - 12
ER -